After adjusting for risk factors, patients in the > 50 nmol/L pre-methotrexate initiation group exhibited a 28% reduced risk of mortality when compared with those in the ≤ 50 nmol/L group
Among other manifestations, patients with PsA and neuropathic pain tended to have higher leptin levels, poor sleep quality, and greater levels of fatigue.
Oligoarticular PsA can significantly affect quality of life even though few joints are affected, and there s a lack of relevant clinical data to guide treatment.
MoonLake Immunotherapeutics AG: MoonLake Immunotherapeutics Reports Third Quarter 2023 Financial Results and Provides a Business Update finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.